Not Yet Recruiting Medication Training Via Ignite Based on Roy Model in Heart Failure: Medication Adherence and Symptom Management NCT07538596 Conditions Hearth Failure With Reduced Ejection Fraction (HFrEF) Locations Suleyman Yalcin City Hospital — Istanbul, Kadikoy, Turkey (Türkiye) View Trial Details
Completed Description of Tolerability of LCZ696 (Sacubitril / Valsartan) in Heart Failure With Reduced Ejection Fraction (HFrEF) Treated in Real Life Setting NCT02690974 Conditions Cardiovascular Diseases, Heart Diseases, Heart Failure, +2 more Locations Novartis Investigative Site — Edmonton, Alberta, Canada Novartis Investigative Site — New Westminster, British Columbia, Canada Novartis Investigative Site — Vancouver, British Columbia, Canada Novartis Investigative Site — Winnipeg, Manitoba, Canada View all 32 locations View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting THE RELATIONSHIP BETWEEN CARDIAC RESYNCHRONİZATION THERAPY RESPONSE IN HEART FAILURE PATIENTS AND YKL-40 LEVELS NCT07469137 Conditions Arrhythmias, Cardiac, Bundle-Branch Block, Cardiac Conduction System Disease, +9 more Locations Trakya University — Edirne, Turkey (Türkiye) View Trial Details
